NCT06032104 Feasibility and Colorectal Benefits of Pulses Supplementation
| NCT ID | NCT06032104 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Colorectal Polyp |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2023-10-27 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2023-10-27 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Beans are a forgotten staple food that shows promise in improving health. The goal of this study is to look at how bean supplementation affects metabolic and bowel health. In the long-term, the investigators believe this research will lead to a better understanding of the impact of beans on bowel health. The investigators also hope that this research study will help us understand ways to improve human diet and prevent colon cancer in the future.
Eligibility Criteria
Inclusions: 1. 30-80 years-old 2. Overweight or obesity (body mass index ≥ 25 kg/m2) 3. Planned for a standard of care colonoscopy for colon cancer screening Exclusions: 1. Intolerance to a bean or high bean consumer based on a screening survey 2. Pregnancy or actively planning to get pregnant 3. Any active gastrointestinal disease resulting in disturbed gut function or malabsorption (e.g., chronic diarrhea or inflammatory bowel disease) 4. Current or history of any malignancy in the past 10 years. 5. Chronic use of opioids, anti-inflammatory drugs, antibiotics, prebiotics, or probiotics within 1 month of study endpoints 6. History of a significant systemic condition (e.g., heart disease, chronic kidney disease, liver dysfunction or immune suppression), or abnormal laboratory markers (e.g., abnormal liver enzymes, creatinine, clotting factors, or low platelets count). The severity of the intolerance to fiber/ the medical conditions/lab markers and eligibility will be defined after the careful interview of the patient/review of the medical records by Dr. Hussan)
Contact & Investigator
Hisham Hussan, MD
PRINCIPAL INVESTIGATOR
UC Davis
Frequently Asked Questions
Who can join the NCT06032104 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 80 Years, studying Colorectal Polyp. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06032104 currently recruiting?
Yes, NCT06032104 is actively recruiting participants. Contact the research team at hhussan@ucdavis.edu for enrollment information.
Where is the NCT06032104 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT06032104 clinical trial?
NCT06032104 is sponsored by University of California, Davis. The principal investigator is Hisham Hussan, MD at UC Davis. The trial plans to enroll 25 participants.